HeartSciences Inc.HSCSNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank17
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P17
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -27.09% |
| Q3 2025 | 7.33% |
| Q2 2025 | -10.07% |
| Q1 2025 | -13.83% |
| Q4 2024 | -2.12% |
| Q3 2024 | 17.09% |
| Q2 2024 | 105.32% |
| Q1 2024 | -32.72% |
| Q4 2023 | 33.89% |
| Q3 2023 | 5.84% |
| Q2 2023 | -16.92% |
| Q1 2023 | -24.23% |
| Q4 2022 | 95.53% |
| Q3 2022 | -67.97% |
| Q2 2022 | 93.93% |
| Q1 2022 | 28.08% |
| Q4 2021 | 36.06% |
| Q3 2021 | -32.47% |
| Q2 2021 | 0.00% |